In cancer, especially in Wilms’ tumor, aberrant methylation of the ICR causes the reactivation of the maternal silent IGF2 allele and the silencing of the active H19 maternal allele [8,48,49,50,51]. This evidence concerns the gene IGF2 and cancer.